CASCINU, STEFANO
CASCINU, STEFANO
Facoltà di Medicina e Chirurgia
5-Fluorouracil pharmacogenomics: still rocking after all these years?
2011-01-01 M., Scartozzi; E., Maccaroni; R., Giampieri; M., Pistelli; A., Bittoni; M. D., Prete; R., Berardi; Cascinu, Stefano
[11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas
2014-01-01 Matteo, Santoni; Cristina, Nanni; Alessandro, Bittoni; Gabriele, Polonara; Alessandro, Paccapelo; Roberto, Trignani; Mariagrazia De, Lisa; Franco, Rychlicki; Luciano, Burattini; Rossana, Berardi; Stefano, Fanti; Cascinu, Stefano
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study)
2017-01-01 Gelsomino, Fabio; Bertolini, Federica; Luppi, Gabriele; Spallanzani, Andrea; Pettorelli, Elisa; Reggiani Bonetti, Luca; Meduri, Bruno; Manco, Gianrocco; Conte, Pierfranco; Cascinu, Stefano
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
2012-01-01 Campanati, A.; Berardi, R.; Onofri, A.; Pierantoni, C.; Conte, I.; Giuliodori, K.; Molinelli, E.; Marcucci, F.; Cascinu, Stefano; Offidani, A.
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index
2022-01-01 Rovesti, G.; Leone, F.; Brandi, G.; Cesario, S.; Scartozzi, M.; Niger, M.; Yoo, C.; Filippi, R.; Casagrande, M.; Silvestris, N.; Santini, D.; Faloppi, L.; Palloni, A.; Aglietta, M.; Bernardini, L.; Cho, H.; Lai, E.; Fenocchio, E.; Pircher, C.; Iacono, D.; De Lorenzo, S.; Sperti, E.; Massa, V.; De Braud, F.; Jeong, J. H.; Aprile, G.; Burgio, V.; Cascinu, S.; Casadei-Gardini, A.
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
2015-01-01 de Braud, Filippo; Cascinu, S.; Spitaleri, G.; Pilz, K.; Clementi, L.; Liu, D.; Sikken, P.; De Pas, T.
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
2012-01-01 G., Gasparini; F., Torino; T., Ueno; Cascinu, Stefano; T., Troiani; A., Ballestrero; R., Berardi; J., Shishido; A., Yoshizawa; Y., Mori; S., Nagayama; P., Morosini; M., Toi
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients
2019-01-01 Weide, B.; Eigentler, T.; Catania, C.; Ascierto, P. A.; Cascinu, S.; Becker, J. C.; Hauschild, A.; Romanini, A.; Danielli, R.; Dummer, R.; Trefzer, U.; Elia, G.; Neri, D.; Garbe, C.
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients
2017-01-01 Laquente, B.; Lopez-Martin, J.; Richards, D.; Illerhaus, G.; Chang, D. Z.; Kim, G.; Stella, P.; Richel, D.; Szcylik, C.; Cascinu, S.; Frassineti, G. L.; Ciuleanu, T.; Hurt, K.; Hynes, S.; Lin, J.; Lin, A. B.; Hoff, D.; Calvo, E.
A randomized, double blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel
2013-01-01 P., Maison Blanche; J. B., Vermorken; T., Goksel; J., Machiels; S., Agarwala; S., Rottey; G., Daugaard; C., Volovat; M., Scheulen; L., Sengeløv; D., Grecea; A., Eniu; E., Jäger; E., Meiri; Cascinu, Stefano; D., Strumberg; G., Demir; M., Clemens; G., Pinotti; M., Nardi; T., Guthrie; E., Boelle; E., Magherini
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study
2019-01-01 Loupakis, F.; Intini, R.; Cremolini, C.; Orlandi, A.; Sartore-Bianchi, A.; Pietrantonio, F.; Pella, N.; Spallanzani, A.; Dell'Aquila, E.; Scartozzi, M.; De Luca, E.; Rimassa, L.; Formica, V.; Leone, F.; Calvetti, L.; Aprile, G.; Antonuzzo, L.; Urbano, F.; Prenen, H.; Negri, F.; Di Donato, S.; Buonandi, P.; Tomasello, G.; Avallone, A.; Zustovich, F.; Moretto, R.; Antoniotti, C.; Salvatore, L.; Calegari, M. A.; Siena, S.; Morano, F.; Ongaro, E.; Cascinu, S.; Santini, D.; Ziranu, P.; Schirripa, M.; Buggin, F.; Prete, A. A.; Depetris, I.; Biason, P.; Lonardi, S.; Zagonel, V.; Fassan, M.; Di Maio, M.
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
2015-01-01 Hidalgo, M.; Cascinu, S.; Kleeff, J.; Labianca, R.; Lohr, J. -M.; Neoptolemos, J.; Real, F. X.; Van Laethem, J. -L.; Heinemann, V.
Adjuvant chemotherapy in colon cancer: can we improve quality of care?
2013-01-01 Cascinu, Stefano
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome
2014-01-01 Panzuto, Francesco; Merola, Elettra; Rinzivillo, Maria; Campana, Davide; Iannicelli, Elsa; Pilozzi, Emanuela; Mercantini, Paolo; Rossi, Michele; Capurso, Gabriele; Scarpa, Aldo; Cascinu, Stefano; Tomassetti, Paola; Falconi, Massimo; Delle Fave, Gianfranco; Partelli, Stefano
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib
2021-01-01 Rapposelli, I. G.; Tada, T.; Shimose, S.; Burgio, V.; Kumada, T.; Iwamoto, H.; Hiraoka, A.; Niizeki, T.; Atsukawa, M.; Koga, H.; Hirooka, M.; Torimura, T.; Iavarone, M.; Tortora, R.; Campani, C.; Lonardi, S.; Tamburini, E.; Piscaglia, F.; Masi, G.; Cabibbo, G.; Giuseppe Foschi, F.; Silletta, M.; Tsuji, K.; Ishikawa, T.; Takaguchi, K.; Kariyama, K.; Itobayashi, E.; Tajiri, K.; Shimada, N.; Shibata, H.; Ochi, H.; Yasuda, S.; Toyoda, H.; Fukunishi, S.; Ohama, H.; Kawata, K.; Tani, J.; Nakamura, S.; Nouso, K.; Tsutsui, A.; Nagano, T.; Tanaka, T.; Itokawa, N.; Okubo, T.; Arai, T.; Imai, M.; Joko, K.; Koizumi, Y.; Hiasa, Y.; Rimini, M.; Ratti, F.; Aldrighetti, L.; Cascinu, S.; Casadei-Gardini, A.
Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
2016-01-01 Scartozzi, M.; Vincent, L.; Chiron, M.; Cascinu, S.
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW
2018-01-01 Muro, K.; Cho, J. Y.; Bodoky, G.; Goswami, C.; Chao, Y.; dos Santos, L. V.; Shimada, Y.; Topuzov, E.; Van Cutsem, E.; Tabernero, J.; Zalcberg, J.; Chau, I.; Cascinu, S.; Cheng, R.; Hsu, Y.; Emig, M.; Orlando, M.; Fuchs, C.
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients
2011-01-01 Scartozzi, M.; Loretelli, C.; Bearzi, I.; Mandolesi, A.; Galizia, E.; Onofri, A.; Pistelli, M.; Bittoni, A.; Berardi, R.; Cascinu, Stefano
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study
2018-01-01 Lazzaro, C.; Barone, C.; Caprioni, F.; Cascinu, S.; Falcone, A.; Maiello, E.; Milella, M.; Pinto, C.; Reni, M.; Tortora, G.
Anal cancer: from an orphan disease to a curable malignancy?
2017-01-01 Cascinu, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5-Fluorouracil pharmacogenomics: still rocking after all these years? | 1-gen-2011 | M., Scartozzi; E., Maccaroni; R., Giampieri; M., Pistelli; A., Bittoni; M. D., Prete; R., Berardi; Cascinu, Stefano | |
| [11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas | 1-gen-2014 | Matteo, Santoni; Cristina, Nanni; Alessandro, Bittoni; Gabriele, Polonara; Alessandro, Paccapelo; Roberto, Trignani; Mariagrazia De, Lisa; Franco, Rychlicki; Luciano, Burattini; Rossana, Berardi; Stefano, Fanti; Cascinu, Stefano | |
| A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study) | 1-gen-2017 | Gelsomino, Fabio; Bertolini, Federica; Luppi, Gabriele; Spallanzani, Andrea; Pettorelli, Elisa; Reggiani Bonetti, Luca; Meduri, Bruno; Manco, Gianrocco; Conte, Pierfranco; Cascinu, Stefano | |
| A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor | 1-gen-2012 | Campanati, A.; Berardi, R.; Onofri, A.; Pierantoni, C.; Conte, I.; Giuliodori, K.; Molinelli, E.; Marcucci, F.; Cascinu, Stefano; Offidani, A. | |
| A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index | 1-gen-2022 | Rovesti, G.; Leone, F.; Brandi, G.; Cesario, S.; Scartozzi, M.; Niger, M.; Yoo, C.; Filippi, R.; Casagrande, M.; Silvestris, N.; Santini, D.; Faloppi, L.; Palloni, A.; Aglietta, M.; Bernardini, L.; Cho, H.; Lai, E.; Fenocchio, E.; Pircher, C.; Iacono, D.; De Lorenzo, S.; Sperti, E.; Massa, V.; De Braud, F.; Jeong, J. H.; Aprile, G.; Burgio, V.; Cascinu, S.; Casadei-Gardini, A. | |
| A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors | 1-gen-2015 | de Braud, Filippo; Cascinu, S.; Spitaleri, G.; Pilz, K.; Clementi, L.; Liu, D.; Sikken, P.; De Pas, T. | |
| A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer | 1-gen-2012 | G., Gasparini; F., Torino; T., Ueno; Cascinu, Stefano; T., Troiani; A., Ballestrero; R., Berardi; J., Shishido; A., Yoshizawa; Y., Mori; S., Nagayama; P., Morosini; M., Toi | |
| A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients | 1-gen-2019 | Weide, B.; Eigentler, T.; Catania, C.; Ascierto, P. A.; Cascinu, S.; Becker, J. C.; Hauschild, A.; Romanini, A.; Danielli, R.; Dummer, R.; Trefzer, U.; Elia, G.; Neri, D.; Garbe, C. | |
| A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients | 1-gen-2017 | Laquente, B.; Lopez-Martin, J.; Richards, D.; Illerhaus, G.; Chang, D. Z.; Kim, G.; Stella, P.; Richel, D.; Szcylik, C.; Cascinu, S.; Frassineti, G. L.; Ciuleanu, T.; Hurt, K.; Hynes, S.; Lin, J.; Lin, A. B.; Hoff, D.; Calvo, E. | |
| A randomized, double blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel | 1-gen-2013 | P., Maison Blanche; J. B., Vermorken; T., Goksel; J., Machiels; S., Agarwala; S., Rottey; G., Daugaard; C., Volovat; M., Scheulen; L., Sengeløv; D., Grecea; A., Eniu; E., Jäger; E., Meiri; Cascinu, Stefano; D., Strumberg; G., Demir; M., Clemens; G., Pinotti; M., Nardi; T., Guthrie; E., Boelle; E., Magherini | |
| A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study | 1-gen-2019 | Loupakis, F.; Intini, R.; Cremolini, C.; Orlandi, A.; Sartore-Bianchi, A.; Pietrantonio, F.; Pella, N.; Spallanzani, A.; Dell'Aquila, E.; Scartozzi, M.; De Luca, E.; Rimassa, L.; Formica, V.; Leone, F.; Calvetti, L.; Aprile, G.; Antonuzzo, L.; Urbano, F.; Prenen, H.; Negri, F.; Di Donato, S.; Buonandi, P.; Tomasello, G.; Avallone, A.; Zustovich, F.; Moretto, R.; Antoniotti, C.; Salvatore, L.; Calegari, M. A.; Siena, S.; Morano, F.; Ongaro, E.; Cascinu, S.; Santini, D.; Ziranu, P.; Schirripa, M.; Buggin, F.; Prete, A. A.; Depetris, I.; Biason, P.; Lonardi, S.; Zagonel, V.; Fassan, M.; Di Maio, M. | |
| Addressing the challenges of pancreatic cancer: Future directions for improving outcomes | 1-gen-2015 | Hidalgo, M.; Cascinu, S.; Kleeff, J.; Labianca, R.; Lohr, J. -M.; Neoptolemos, J.; Real, F. X.; Van Laethem, J. -L.; Heinemann, V. | |
| Adjuvant chemotherapy in colon cancer: can we improve quality of care? | 1-gen-2013 | Cascinu, Stefano | |
| Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome | 1-gen-2014 | Panzuto, Francesco; Merola, Elettra; Rinzivillo, Maria; Campana, Davide; Iannicelli, Elsa; Pilozzi, Emanuela; Mercantini, Paolo; Rossi, Michele; Capurso, Gabriele; Scarpa, Aldo; Cascinu, Stefano; Tomassetti, Paola; Falconi, Massimo; Delle Fave, Gianfranco; Partelli, Stefano | |
| Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib | 1-gen-2021 | Rapposelli, I. G.; Tada, T.; Shimose, S.; Burgio, V.; Kumada, T.; Iwamoto, H.; Hiraoka, A.; Niizeki, T.; Atsukawa, M.; Koga, H.; Hirooka, M.; Torimura, T.; Iavarone, M.; Tortora, R.; Campani, C.; Lonardi, S.; Tamburini, E.; Piscaglia, F.; Masi, G.; Cabibbo, G.; Giuseppe Foschi, F.; Silletta, M.; Tsuji, K.; Ishikawa, T.; Takaguchi, K.; Kariyama, K.; Itobayashi, E.; Tajiri, K.; Shimada, N.; Shibata, H.; Ochi, H.; Yasuda, S.; Toyoda, H.; Fukunishi, S.; Ohama, H.; Kawata, K.; Tani, J.; Nakamura, S.; Nouso, K.; Tsutsui, A.; Nagano, T.; Tanaka, T.; Itokawa, N.; Okubo, T.; Arai, T.; Imai, M.; Joko, K.; Koizumi, Y.; Hiasa, Y.; Rimini, M.; Ratti, F.; Aldrighetti, L.; Cascinu, S.; Casadei-Gardini, A. | |
| Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC) | 1-gen-2016 | Scartozzi, M.; Vincent, L.; Chiron, M.; Cascinu, S. | |
| Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW | 1-gen-2018 | Muro, K.; Cho, J. Y.; Bodoky, G.; Goswami, C.; Chao, Y.; dos Santos, L. V.; Shimada, Y.; Topuzov, E.; Van Cutsem, E.; Tabernero, J.; Zalcberg, J.; Chau, I.; Cascinu, S.; Cheng, R.; Hsu, Y.; Emig, M.; Orlando, M.; Fuchs, C. | |
| Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients | 1-gen-2011 | Scartozzi, M.; Loretelli, C.; Bearzi, I.; Mandolesi, A.; Galizia, E.; Onofri, A.; Pistelli, M.; Bittoni, A.; Berardi, R.; Cascinu, Stefano | |
| An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study | 1-gen-2018 | Lazzaro, C.; Barone, C.; Caprioni, F.; Cascinu, S.; Falcone, A.; Maiello, E.; Milella, M.; Pinto, C.; Reni, M.; Tortora, G. | |
| Anal cancer: from an orphan disease to a curable malignancy? | 1-gen-2017 | Cascinu, S. |